[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

AMA Petitions NRC




The following notice appeared in last Thursday's Federal Register:
__________________________________________________________________
Citation="59 FR 37950"
Group="energy"
Type="PROPOSED RULE"
Department="NUCLEAR REGULATORY COMMISSION"
Agency="NUCLEAR REGULATORY COMMISSION"
Subject="American Medical Association"
<HEADER>
NUCLEAR REGULATORY COMMISSION 

10 CFR Parts 20 and 35 

[Docket No. PRM-35-11] 

ACTION: Petition for rulemaking; Notice of receipt. 
------------------------------------------------------------
SUMMARY: The Nuclear Regulatory Commission (NRC) is publishing 
for public comment a notice of receipt of a petition for rulemaking, 
dated March 28, 1994, which was filed with the Commission by 
the American Medical Association (AMA). The petition was docketed 
by the NRC on April 20, 1994, and has been assigned Docket No. 
PRM-35-11. The petitioner requests that the NRC amend its regulations 
to recognize that current medical practice concerning the therapeutic 
uses of I^131, particularly in outpatient settings, is effective 
and safe for the public. The petitioner also requests that the 
NRC formally recognize that adequate home confinement precautions 
reduce the hazards associated with radioisotopes sufficiently 
to eliminate the need for hospitalization following therapeutic 
administration of radiopharmaceuticals. The petitioner also 
requests that the NRC increase the external radiation limit 
for the public from 100 mRem/year to 500 mRem/year. 

DATES: Submit comments by October 11, 1994. Comments received 
-----------------------------------------------------------------------------
Full access to this file is restricted to subscribers only.  To become a
subscriber to this service, please read the information provided at the
top level of the Counterpoint Publishing Internet Federal Register Gopher.

Please send all comments to 'info@counterpoint.com'  -- Thanks.
----------------------------------------------------------------------------